269 related articles for article (PubMed ID: 22000652)
41. Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?
Gul A; Zager P
Curr Diab Rep; 2018 Mar; 18(4):18. PubMed ID: 29497863
[TBL] [Abstract][Full Text] [Related]
42. [Uric acid and the prevention of renal and cardiovascular disease in CKD].
Teatini U
G Ital Nefrol; 2012; 29 Suppl 58():S46-8. PubMed ID: 23229602
[TBL] [Abstract][Full Text] [Related]
43. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
44. Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort study.
Kobayashi M; Hirawa N; Morita S; Yatsu K; Kobayashi Y; Yamamoto Y; Saka S; Toya Y; Yasuda G; Umemura S
Am J Kidney Dis; 2010 Sep; 56(3):468-76. PubMed ID: 20537454
[TBL] [Abstract][Full Text] [Related]
45. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
46. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
[TBL] [Abstract][Full Text] [Related]
47. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
Brandenburg V; Floege J
Med Klin (Munich); 2006 Mar; 101 Suppl 1():158-62. PubMed ID: 16802544
[TBL] [Abstract][Full Text] [Related]
48. Serum uric acid: a risk factor and a target for treatment?
Feig DI; Mazzali M; Kang DH; Nakagawa T; Price K; Kannelis J; Johnson RJ
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S69-73. PubMed ID: 16565251
[TBL] [Abstract][Full Text] [Related]
49. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
50. Renal effects of uric acid: hyperuricemia and hypouricemia.
Park JH; Jo YI; Lee JH
Korean J Intern Med; 2020 Nov; 35(6):1291-1304. PubMed ID: 32872730
[TBL] [Abstract][Full Text] [Related]
51. Does uric acid-lowering treatment slow the progression of chronic kidney disease? A meta-analysis of randomized controlled trials.
Bignardi PR; Ido DH; Garcia FAL; Braga LM; Delfino VDA
Nefrologia (Engl Ed); 2023; 43(2):167-181. PubMed ID: 36564223
[TBL] [Abstract][Full Text] [Related]
52. Uric acid as a target of therapy in CKD.
Jalal DI; Chonchol M; Chen W; Targher G
Am J Kidney Dis; 2013 Jan; 61(1):134-46. PubMed ID: 23058478
[TBL] [Abstract][Full Text] [Related]
53. Uric acid and hypertension.
Feig DI
Semin Nephrol; 2011 Sep; 31(5):441-6. PubMed ID: 22000651
[TBL] [Abstract][Full Text] [Related]
54. [Uric acid, the kidney and cardiovascular mortality].
Santoro A; Mandreoli M
G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005872
[TBL] [Abstract][Full Text] [Related]
55. Uric acid and fructose: potential biological mechanisms.
Lanaspa MA; Tapia E; Soto V; Sautin Y; Sánchez-Lozada LG
Semin Nephrol; 2011 Sep; 31(5):426-32. PubMed ID: 22000649
[TBL] [Abstract][Full Text] [Related]
56. Uric acid, hypertension, and cardiovascular and renal complications.
Zoccali C; Mallamaci F
Curr Hypertens Rep; 2013 Dec; 15(6):531-7. PubMed ID: 24072559
[TBL] [Abstract][Full Text] [Related]
57. Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis.
Su X; Xu B; Yan B; Qiao X; Wang L
PLoS One; 2017; 12(11):e0187550. PubMed ID: 29095953
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological urate-lowering approaches in chronic kidney disease.
Li X; Liu J; Ma L; Fu P
Eur J Med Chem; 2019 Mar; 166():186-196. PubMed ID: 30769179
[TBL] [Abstract][Full Text] [Related]
59. Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue.
Hu C; Wu X
Int Urol Nephrol; 2019 Dec; 51(12):2227-2233. PubMed ID: 31463702
[TBL] [Abstract][Full Text] [Related]
60. The Pathophysiology of Uric Acid on Renal Diseases.
Sánchez-Lozada LG
Contrib Nephrol; 2018; 192():17-24. PubMed ID: 29393088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
